Aspects of Inhibition of Myometrial Hyperactivity in Primary Dysmenorrhea

References

• Abe Y. Effects of changing the ionic environment on passive and active membrane properties of pregnant rat uterus. J Physiol (Lond) 1971; 214: 173
   Google Scholar
• Anderson A. B. M., Haynes P. J., Fraser I. S., Turnbull A. C. Trial of prostaglandin-synthetase inhibition in primary dysmenorrhoea. Lancet 1979; i: 345
   Google Scholar
• Andersson K.-E., Ulmsten U. Effects of nifedipine on myometrial activity and lower abdominal pain in women with primary dysmenorrhoea. Br J Obstet Gynaecol 1978; 85: 142
   PubMedGoogle Scholar
• Andersson K.-E. Side effects of prostaglandin synthetase inhibitors. Acta Obstet Gynecol Scand Suppl 1979; 87: 101
   Google Scholar
• Andersson K.-E., Bengtsson B. Effects of beta-adrenoceptor agonists on electrical and mechanical activity of the myometrium. Acta Pharmacol Toxicol 44, Suppl 1980; 11: 64
   Google Scholar
• Berry C., McGuire F. Menstrual distress and acceptance of sexual role. Am J Obstet Gynecol 1972; 124: 83
   Google Scholar
• Blaustein M. P. Sodium ions, calcium ions, blood pressure regulation and hypertension: a reassessment and a hypothesis. Am J Physiol 1975; 232: C165
   Google Scholar
• Bolton T. B. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 1979; 59: 606
   PubMed Web of Science ®Google Scholar
• Brading A. Calcium-induced increase in membrane permeability in the guinea pig taenia coli: evidence for involvement of a sodium-calcium exchange machanism. J Physiol (Lond) 1978; 275: 65
   Google Scholar
• Brogden R. N., Heel R. C., Pakes G. E., Speight T. M., Avery G. S. Diflunisal: A review of its pharmacological properties and therapeutic use in pain and musculoskeletal strains and sprains and pain in osteoarthritis. Drugs 1980; 19: 84
   PubMed Web of Science ®Google Scholar
• Casteels R., van Breemen C. Active and possive Ca2+ fluxes across cell membranes of the guinea-pig taenia coli. Pfluegers Arch 1975; 359: 197
   Google Scholar
• Casteels R. Electro- and pharmacomechanical coupling in vascular smooth muscle. Chest 1980; 78: 150
   Google Scholar
• Cobo E., Cifuentes R., De Villamizar M. Inhibition of menstrual uterine motility during water diuresis. Am J Obstet Gynecol 1978; 132: 313
   PubMed Web of Science ®Google Scholar
• Collier H. O. J., Sweatman W. J. F. Antagonism by fenamates of prostaglandin F2α and of slow reacting substance on human bronchial muscle. Nature 1968; 219: 864
   Web of Science ®Google Scholar
• Csapo A. J., Pulkkinen M. O., Henzl M. R. The effect of naproxen-sodium on the intrauterine pressure and menstrual pain of dysmenorrhoic patients. Prostaglandins 1977; 13: 193
   Google Scholar
• Daniel E. E., Janis R. A. Calcium regulation in the uterus. Pharmacol Ther B 1975; 1: 695
   Google Scholar
• Dawood M. Y. Dysmenorrhoea and prostaglandins: Pharmacological and therapeutic considerations. Drugs 1981; 22: 42
   PubMed Web of Science ®Google Scholar
• Filler W. W., Hall W. C. Dysmenorrhea and its therapy: a uterine contractility study. Am J Obstet Gynecol 1970; 106: 104
   Google Scholar
• Fleckenstein A. Specific pharmacology of calcium in myocardium cardiac pacemakers, and vascular smooth muscle. Ann Rev Pharmacol Toxicol 1977; 17: 149
   PubMed Web of Science ®Google Scholar
• Forman A., Andersson K.-E., Persson C. G. A., Ulmsten U. Relaxant effects of nifedipine on isolated, human myometrium. Acta Pharmacol Toxicol 1979; 45: 81
   Google Scholar
• Forman A., Ulmsten U., Andersson K.-E. Combined effects of diflunisal and nifedipine on uterine contractility in dysmenorrhoeic patients, Subm. for publ
   Google Scholar
• Fuchs A. R., Coutinho E. M. Suppression of uterine activity during menstruation by expansion of the plasma volume. Acta Endocrinol 1971; 66: 183
   PubMedGoogle Scholar
• Golenhofen K. Differentiation of calcium activation processes in smooth muscle using selective antagonists. Smooth Muscle, E. Bülbring, H. F. Brading, A. W. Jones, T. Tomita. E. Arnold. 1981; 157
   Google Scholar
• Hamann G. O. Severe primary dysmenorrhoea treated with naproxen. A prospective double-blind, cross-over investigation. Prostaglandins 1980; 19: 651
   Google Scholar
• Hirt M., Kurz R., Ross W. D. The relationship between dysmenorrhoea and selected personality variables. Psychomatics 1967; 8: 350
   PubMed Web of Science ®Google Scholar
• Jacobson J., Cavalli-Björkman K., Lundström V., Nilsson B., Norbeck M. Prostaglandin synthetase inhibitors and dysmenorrhea. A survey and personal clinical experience. Acta Obstet Gynecol Scand Suppl 1919; 87: 73
   Google Scholar
• Kao C. Y., McCulloch J. R. Ionic currents in the uterine smooth muscle. J Physiol (Lond) 1975; 246: 1
   Google Scholar
• Lundström V., Gréen K. Endogenous levels of prostaglandin F2α and its main metabolites in plasma and endometrium of normal and dysmenorrheic women. Am J Obstet Gynecol 1978; 130: 640
   PubMed Web of Science ®Google Scholar
• Lundström V., Gréen K., Wiqvist N. Prostaglandins, indomethacin and dysmenorrhoea. Prostaglandins 1976; 11: 893
   PubMed Web of Science ®Google Scholar
• Lundström V., Gréen K., Svanborg K. Endogenous prostaglandins in dysmenorrhea and the effect of prostaglandin synthetase inhibitors (PGSI) on uterine contractility. Acta Obstet Gynecol Scand Suppl 1979; 87: 51
   Google Scholar
• Lundström V., Bygdeman M. Prostaglandin F2α and E2 in primary dysmenorrhoea. Advances in Prostaglandin and Thromboxane Research, B. Samuelsson, P. W. Ramwell, R. Paoletti. Raven Press, New York 1980; vol. 8: 1455
   Google Scholar
• Melin P., Vilhardt H., Lindeberg G., Larsson L. E., Åkerlund M. Inhibitory effect of 0-alkylated analogues of oxytocin and vasopressin on human and rat myometrial activity. J Endocrinol 1981; 88: 173
   Google Scholar
• Mironneau J. Excitation-contraction coupling in voltage clamped uterine smooth muscle. J Physiol (Lond) 1973; 233: 127
   Google Scholar
• Mironneau J. Voltage clamp analysis of the ionic currents in uterine smooth muscle using the double sucrose-gap method. Pfluegers Arch Ges Physiol 1974; 352: 197
   Google Scholar
• Pickles V. R., Hall W. J., Best F. A., Smith G. N. Prostaglandins in endometrium and menstrual fluid from normal and dysmenorrhoeic subjects. Br J Obstet Gynaecol 1965; 72: 185
   Google Scholar
• Sandahl B., Ulmsten U., Andersson K.-E. Trial of the calcium antagonist nifedipine in the treatment of primary dysmenorrhoea. Arch Gynaekol 1979; 227: 147
   Google Scholar
• Shen T. Y. Prostaglandin synthetase inhibitors. Antiinflammatory Drugs. Handbook of Experimental Pharmacology, J. R. Vane, S. H. Ferreira. Springer-Verlag, Berlin, Heidelberg, New York 1979; vol. 50/II: 305
   Google Scholar
• Somlyo A. P., Somlyo A. V. Electromechanical and pharmacomechanical coupling in vascular smooth muscle. J Pharmacol Exp Ther 1968; 159: 129
   PubMed Web of Science ®Google Scholar
• Strömberg P., Forsling M. L., Åkerlund M. Effects of prostaglandin inhibition on vasopressin levels in women with primary dysmenorrhea. Obstet Gynecol, In press
   Google Scholar
• Ulmsten U., Andersson K.-E., Forman A. Relaxing effects of nifedipine on the non-pregnant human uterus in vitro and in vivo. Obstet Gynecol 1978; 52: 436
   Google Scholar
• Ulmsten U., Andersson K.-E. Multichannel pressure recording by means of microtransducers. Acta Obstet Gynecol Scand 1979; 58: 115
   Web of Science ®Google Scholar
• Vassort G. Voltage clamp analysis of transmembrane ionic currents in guinea-pig myometrium evidence for an initial potassium activation triggered by calcium influx. J Physiol (Lond) 1975; 252: 713
   Google Scholar
• Wittkower E., Wilson A. T. M. Dysmenorrhoea and sterility. Personality studies. Br Med J 1940; ii: 586
   Google Scholar
• Woodbury R. A., Torpin R., Child G. P., Watson H., Jarboe M. Myometrial physiology and its relation to pelvic pain. JAMA 1947; 134: 1081
   PubMed Web of Science ®Google Scholar
• Ylikorkala O., Dawood M. Y. New concepts in dysmenorrhea. Am J Obstet Gynecol 1978; 130: 833
   PubMed Web of Science ®Google Scholar
• Åkerlund M., Andersson K.-E., Ingemarsson I. Effects of terbutaline on myometrial activity, uterine blood flow, and lower abdominal pain in women with primary dysmenorrhoea. Br J Obstet Gynaecol 1976; 83: 673
   PubMedGoogle Scholar
• Åkerlund M., Strömberg P., Forsling M. L. Primary dysmenorrhoea and vasopressin. Br J Obstet Gynaecol 1979; 86: 484
   PubMedGoogle Scholar